Log in to save to my catalogue

Risk of severe illness from COVID-19 in patients with metabolic dysfunction-associated fatty liver d...

Risk of severe illness from COVID-19 in patients with metabolic dysfunction-associated fatty liver d...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2404043476

Risk of severe illness from COVID-19 in patients with metabolic dysfunction-associated fatty liver disease and increased fibrosis scores

About this item

Full title

Risk of severe illness from COVID-19 in patients with metabolic dysfunction-associated fatty liver disease and increased fibrosis scores

Publisher

England: BMJ Publishing Group Ltd and British Society of Gastroenterology

Journal title

Gut, 2020-08, Vol.69 (8), p.1545-1547

Language

English

Formats

Publication information

Publisher

England: BMJ Publishing Group Ltd and British Society of Gastroenterology

More information

Alternative Titles

Full title

Risk of severe illness from COVID-19 in patients with metabolic dysfunction-associated fatty liver disease and increased fibrosis scores

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_2404043476

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2404043476

Other Identifiers

ISSN

0017-5749

E-ISSN

1468-3288

DOI

10.1136/gutjnl-2020-321611

How to access this item